Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lami.fit offers a commercial AI-powered digital health platform that uses DNA methylation and blood/body marker analysis to provide highly personalized nutrition and lifestyle plans. The company claims to help prevent or reverse lifestyle diseases such as diabetes and heart disease by focusing on predictive analytics and preventive interventions. It has served thousands of users including elite athletes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lami.fit.